Literature DB >> 22428846

The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Ji Hoon Yoo1, Ian Kitchen, Alexis Bailey.   

Abstract

Cocaine addiction has become a major concern in the UK as Britain tops the European 'league table' for cocaine abuse. Despite its devastating health and socio-economic consequences, no effective pharmacotherapy for treating cocaine addiction is available. Identifying neurochemical changes induced by repeated drug exposure is critical not only for understanding the transition from recreational drug use towards compulsive drug abuse but also for the development of novel targets for the treatment of the disease and especially for relapse prevention. This article focuses on the effects of chronic cocaine exposure and withdrawal on each of the endogenous opioid peptides and receptors in rodent models. In addition, we review the studies that utilized opioid peptide or receptor knockout mice in order to identify and/or clarify the role of different components of the opioid system in cocaine-addictive behaviours and in cocaine-induced alterations of brain neurochemistry. The review of these studies indicates a region-specific activation of the µ-opioid receptor system following chronic cocaine exposure, which may contribute towards the rewarding effect of the drug and possibly towards cocaine craving during withdrawal followed by relapse. Cocaine also causes a region-specific activation of the κ-opioid receptor/dynorphin system, which may antagonize the rewarding effect of the drug, and at the same time, contribute to the stress-inducing properties of the drug and the triggering of relapse. These conclusions have important implications for the development of effective pharmacotherapy for the treatment of cocaine addiction and the prevention of relapse.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428846      PMCID: PMC3402766          DOI: 10.1111/j.1476-5381.2012.01952.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  199 in total

1.  Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors.

Authors:  Fabrice Billet; Nathalie Dourmap; Jean Costentin
Journal:  Eur J Neurosci       Date:  2004-11       Impact factor: 3.386

2.  Dopamine antagonist and "binge' cocaine effects on rat opioid and dopamine transporter mRNAs.

Authors:  R Spangler; Y Zhou; C E Maggos; A Zlobin; A Ho; M J Kreek
Journal:  Neuroreport       Date:  1996-09-02       Impact factor: 1.837

Review 3.  Microarray studies of psychostimulant-induced changes in gene expression.

Authors:  Vadim Yuferov; David Nielsen; Eduardo Butelman; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

4.  Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.

Authors:  C A Heidbreder; S Schenk; B Partridge; T S Shippenberg
Journal:  Synapse       Date:  1998-11       Impact factor: 2.562

5.  Kappa opioid inhibition of morphine and cocaine self-administration in rats.

Authors:  S D Glick; I M Maisonneuve; J Raucci; S Archer
Journal:  Brain Res       Date:  1995-05-29       Impact factor: 3.252

6.  Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens.

Authors:  A Rosin; S Lindholm; J Franck; J Georgieva
Journal:  Neurosci Lett       Date:  1999-11-05       Impact factor: 3.046

Review 7.  Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Authors:  Mary Jeanne Kreek; Gavin Bart; Charles Lilly; K Steven LaForge; David A Nielsen
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

Review 8.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

9.  Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain.

Authors:  J A Crespo; J Manzanares; J M Oliva; J Corchero; T Palomo; E Ambrosio
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

10.  Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved.

Authors:  D Alvarez Fischer; M K Schäfer; B Ferger; S Gross; R Westermann; E Weihe; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-03       Impact factor: 3.000

View more
  12 in total

1.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 3.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 4.  Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.

Authors:  William W Stoops; Craig R Rush
Journal:  Expert Rev Clin Pharmacol       Date:  2014-04-09       Impact factor: 5.045

Review 5.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

6.  Effect of Sinomenine on the Morphine-Dependence and Related Neural Mechanisms in Mice.

Authors:  Miao Fang; Junkui Li; Daoqi Zhu; Chaohua Luo; Chan Li; Chen Zhu; Menglin Fan; Ken Kin-Lam Yung; Zhixian Mo
Journal:  Neurochem Res       Date:  2017-11-08       Impact factor: 3.996

Review 7.  15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.

Authors:  Pauline Charbogne; Brigitte L Kieffer; Katia Befort
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

Review 8.  Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Authors:  Heinz Steiner; Vincent Van Waes
Journal:  Prog Neurobiol       Date:  2012-10-17       Impact factor: 11.685

Review 9.  Neurodevelopmental origins of substance use disorders: Evidence from animal models of early-life adversity and addiction.

Authors:  Sophia C Levis; Tallie Z Baram; Stephen V Mahler
Journal:  Eur J Neurosci       Date:  2021-04-25       Impact factor: 3.698

Review 10.  Neuropsychological Functions of μ- and δ-Opioid Systems.

Authors:  Anna G Polunina; Evgeny A Bryun
Journal:  ISRN Addict       Date:  2013-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.